These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24646121)

  • 1. Proteomics in translational cancer research: biomarker discovery for clinical applications.
    Cho WC
    Expert Rev Proteomics; 2014 Apr; 11(2):131-3. PubMed ID: 24646121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Casting doubt on the traditional approach of cancer biomarker discovery through proteomics.
    Kondo T
    Expert Rev Proteomics; 2014 Feb; 11(1):9-12. PubMed ID: 24351084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics biomarkers for non-small cell lung cancer.
    Kisluk J; Ciborowski M; Niemira M; Kretowski A; Niklinski J
    J Pharm Biomed Anal; 2014 Dec; 101():40-9. PubMed ID: 25175018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral cancer proteomics.
    Hu S; Wong DT
    Curr Opin Mol Ther; 2007 Oct; 9(5):467-76. PubMed ID: 17932810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
    Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
    Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches--a prostate cancer perspective.
    Matharoo-Ball B; Ball G; Rees R
    Vaccine; 2007 Sep; 25 Suppl 2():B110-21. PubMed ID: 17916461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer classification by proteomic technologies: current state of knowledge.
    Lam SW; Jimenez CR; Boven E
    Cancer Treat Rev; 2014 Feb; 40(1):129-38. PubMed ID: 23891266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics-driven cancer biomarker discovery: looking to the future.
    Simpson RJ; Bernhard OK; Greening DW; Moritz RL
    Curr Opin Chem Biol; 2008 Feb; 12(1):72-7. PubMed ID: 18295612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomics and proteomics approaches for biomarker discovery in sporadic colorectal cancer with metastasis.
    González-González M; Garcia JG; Montero JA; Fernandez LM; Bengoechea O; Muñez OB; Orfao A; Sayagues JM; Fuentes M
    Cancer Genomics Proteomics; 2013; 10(1):19-25. PubMed ID: 23382583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
    Wang C; Fang X; Lee CS
    Methods Mol Biol; 2013; 984():1-12. PubMed ID: 23386332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human tear proteomics and peptidomics in ophthalmology: Toward the translation of proteomic biomarkers into clinical practice.
    Azkargorta M; Soria J; Acera A; Iloro I; Elortza F
    J Proteomics; 2017 Jan; 150():359-367. PubMed ID: 27184738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncoproteomics: current trends and future perspectives.
    Cho WC; Cheng CH
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons for tumor biomarker trials: vicious cycles, scientific method & developing guidelines.
    Hayes D; Raison C
    Expert Rev Mol Diagn; 2015 Feb; 15(2):165-9. PubMed ID: 25548983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating biomarker panels for targeted therapy in brain tumors.
    Tanase C; Albulescu R; Codrici E; Popescu ID; Mihai S; Enciu AM; Cruceru ML; Popa AC; Neagu AI; Necula LG; Mambet C; Neagu M
    Future Oncol; 2015; 11(3):511-24. PubMed ID: 25241806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.
    Issaq HJ; Waybright TJ; Veenstra TD
    Electrophoresis; 2011 Apr; 32(9):967-75. PubMed ID: 21449066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer: a proteomic disease.
    Li G; Xiao Z; Liu J; Li C; Li F; Chen Z
    Sci China Life Sci; 2011 May; 54(5):403-8. PubMed ID: 21455689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: state of the art and new perspectives.
    Fontana S; Saieva L; Taverna S; Alessandro R
    Proteomics; 2013 May; 13(10-11):1581-94. PubMed ID: 23401131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry: uncovering the cancer proteome for diagnostics.
    van der Merwe DE; Oikonomopoulou K; Marshall J; Diamandis EP
    Adv Cancer Res; 2007; 96():23-50. PubMed ID: 17161675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.